eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

3/2018
vol. 43
 
Share:
Share:
more
 
 
abstract:
Short communication

Anti-lamin A/C antibodies in patients with Behçet’s disease

Peng Chen, Hai Yan, Wen Zhang, Chunhe Yang, Hongwu Du

Centr Eur J Immunol 2018; 43 (3): 358-361
Online publish date: 2018/10/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Lamin A/C has been identified as a target antigen of anti-endothelial cell antibodies in vasculitis. Behçet’s disease (BD) is a chronic vasculitis with unclear pathogenesis. Self-antibodies have been found to play an important role in the pathological process of BD. The aim of this study was to verify whether lamin A/C is an autoantigen of BD. First, the human lamin A/C protein was cloned and purified and verified by Western blotting. Next, a homemade ELISA kit was used to test the presence of anti-lamin A/C antibodies in BD patients. This is the first time it has been certified that lamin A/C is an autoantigen of BD. The reactivity of serum IgG against recombinant human lamin A/C was detected in 7 of 31 BD patients (23%) and 3 of 32 healthy controls (HC) (9%).
keywords:

Behçet’s disease, autoantigen, lamin A/C

references:
Régent A, Lofek S, Dib H, et al. (2014): Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: A proteomic approach. Clin Immunol 153: 123-135.
Régent A, Dib H, Ly KH, et al. (2011): Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach. Arthritis Res Ther 13: R107.
Aydìntug AO, Tokgöz G, D’Cruz DP, et al. (1993): Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol 67: 157-162.
Cho SB, Ahn KJ, Kim do H, et al. (2012): Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behcet’s disease. J Invest Dermatol 132: 601-608.
Chen P, Yang W, Tian Y, et al. (2015): Electron transfer flavoprotein subunit beta is a candidate endothelial cell autoantigen in Behçet’s disease. PLoS One 10: e0124760.
Chen P, Shi L, Jiang Y, et al. (2014): Identification of heat shock protein 27 as a novel autoantigen of Behçet’s disease. Biochem Biophys Res Commun 456: 866-871.
Chen P, Yan H, Tian Y, et al. (2015): Annexin A2 as a target endothelial cell membrane autoantigen in Behçet’s disease. Sci Rep 5: 8162.
Xun Y, Chen P, Yan H, et al. (2014): Identification of prohibitin as an antigen in Behcet’sdisease. Biochem Biophys Res Commun 451: 389-393.
International Study Group for Behçet’s Disease (1990): Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078-1080.
Goizet C, Yaou RB, Demay L, et al. (2004): A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia. J Med Genet 41: e29.
Nesher G, Margalit R, Ashkenazi YJ (2001): Anti-nuclear envelope antibodies: clinical associations. Semin Arthritis Rheum 30: 313-320.
Goizet C, Yaou RB, Demay L, et al. (2008): Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood 111: 4559-4570.
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD), (2014): The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28: 338-347.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe